Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Active, not recruiting - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Active, not recruiting - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Recruiting - verified September 2013

Condition : Juvenile Idiopathic Arthritis Intervention : Drug: 800 mg ibuprofen/26.6 mg famotidine Sponsors : Horizon Pharma, Inc.; Horizon Pharma, Inc.; Pediatric Rheumatology Collaborative Study Gro...

Condition : Rheumatoid Arthritis Interventions : Drug: Tocilizumab, Abatacept; Drug: Decrease Tocilizumab, Abatacept Sponsors : Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux...

Condition : Osteoarthritis Interventions : Drug: Duloxetine; Drug: Sugar pill Sponsors : Northwestern University; Northwestern University; Eli Lilly and Company Recruiting - verified September 2013

Condition : Osteoarthritis Interventions : Drug: Duloxetine; Drug: Sugar pill Sponsors : Northwestern University; Eli Lilly and Company Recruiting - verified February 2014

Condition : Rheumatoid Arthritis Interventions : Drug: Folic Acid; Drug: Placebo Sponsor : Postgraduate Institute of Medical Education and Research Completed - verified February 2014

Givinostat is expected to exert a clinically relevant therapeutic effect on polyarticular JIA through the inhibition of the production/release of pro-inflammatory cytokines, such as IL-1β, IL-6 and TN...

Condition : Lupus Arthritis, Systemic Lupus Erythematosus Interventions : Drug: AMG 557; Drug: Matching Placebo Sponsor : Amgen Recruiting - verified November 2013